Vitamin A regulation of gene expression: molecular mechanism of a prototype gene

Journal of Nutritional Biochemistry

Volumn 18, Issue 8, 2007, Pages 497-508

  McGrane, Mary M ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; CELL NUCLEUS RECEPTOR; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOL; VITAMIN D RECEPTOR;

DNA RESPONSIVE ELEMENT; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; NUCLEOSOME; NUTRIGENOMICS; REVIEW; TRANSCRIPTION REGULATION; VITAMIN INTAKE;

CHROMATIN; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION; HUMANS; MODELS, GENETIC; NUTRITIONAL STATUS; PHOSPHORYLATION; RECEPTORS, RETINOIC ACID; RETINOIDS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; VITAMIN A;

EID: 34447282494     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2006.10.006     Document Type: Review

References (142)

1. Mangelsdorf D.J., and Evans R.M. The RXR heterodimers and orphan receptors. Cell 83 (1995) 841-850
2. Chambon P. A decade of molecular biology to retinoic acid receptors. FASEB J 10 (1996) 940-954
3. Laudet V., and Gronemeyer H. Nuclear receptor factsbook (2001), Academic Press, London
4. Mangelsdorf D.J., Thummel C., Reato M., Herrlich P., Schutz G., Umesono K., et al. The nuclear receptor superfamily: the second decade. Cell 83 (1995) 835-839
5. Heyman R.A., Mandelsdorf D.J., Dyck J.A., Stein R.B., Eichele G., Evans R.M., et al. 9-Cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68 (1992) 397-406
6. Chambon P., Zelent A., Petkovich M., Mendelsohn C., Leroy P., Drust A., et al. The family of retinoic acid nuclear receptors. In: Saurat J.H. (Ed). Retinoids: 10 years on (1991), Karger, Basel 10-27
7. Kliewer S.A., Umesono K., Noonan D.J., Heyman R.A., and Evans R.M. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358 (1992) 771-774
8. Forman B.M., Umesono K., Chen J., and Evans R.M. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81 (1995) 541-550
9. Willy P.J., Umesono K., Ong E.S., Evans R.M., Heyman R.A., and Mangelsdorf D.J. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 9 (1995) 1033-1045
10. Perlman T., Rangarajan P.N., Umesono K., and Evans R.M. Determinants for selective RAR and TR recognition of direct repeat HREs. Genes Dev 7 (1993) 1411-1422
11. Perlmann T., and Jansson L. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev 9 (1995) 769-782
12. Mangelsdorf D.J., Borgmeyer U., Heyman R.A., Zhou J.Y., Ong E.S., Oro A.E., et al. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev 6 (1992) 329-344
13. Aranda A., and Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev 81 (2001) 1269-1304
14. Desvergne B., Michalik L., and Wahli W. Transcriptional regulation of metabolism. Physiol Rev 86 (2006) 465-514
15. Luisi B.F., Xu W.X., Otwinowski A., Freedman L.P., Yamamoto K.R., and Sigler P.B. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352 (1991) 497-505
16. Lee M.S., Kliewer S.A., Provencal J., Wright P.E., and Evans R.M. Structure of the retinoid X receptor alpha DNA binding domain: a helix required for homodimeric DNA binding. Science 260 (1993) 1117-1121
17. Schwabe J.W., Chapman L., Finch J.T., and Rhodes D. The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell 75 (1993) 567-578
18. Chakravarti D., LaMorte V.J., Nelson M.C., Nakajima T., Schulman I.G., Juguilon H., et al. Role of CBP/p300 in nuclear receptor signalling. Nature 383 (1996) 99-103
19. Glass C.K., and Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14 (2000) 121-141
20. Wurtz J.M., Bourguet W., Renaud J.P., Vivat V., Chambon P., Moras D., et al. A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol 3 (1996) 87-94
21. de The H., Vivanco-Ruiz M.M., Tiollais P., Stunnenberg H., and Dejean A. Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature 343 (1990) 177-180
22. Leid M., Kastner P., and Chambon P. Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem Sci 17 (1992) 427-433
23. Rastinejad F., Wagner T., Zhao Q., and Khorasanizadeh S. Structure of the RXR-RAR DNA-binding complex on the retinoic acid response element DR1. EMBO J 19 (2000) 1045-1054
24. Mangelsdorf D.J., Umesono K., Kliewer S.A., Borgmeyer U., Ong E.S., and Evans R.M. A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell 66 (1991) 555-561
25. Renaud J.P., Rochel N., Ruff M., Vivat V., Chambon P., Gronemeyer H., et al. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature 378 (1995) 681-689
26. Moras D., and Gronemeyer H. The nuclear receptor ligand-binding domain: structure and function. Curr Opin Cell Biol 10 (1998) 384-391
27. Onate S.A., Boonyaratanakornkit V., Spencer T.E., Tsai S.Y., Tsai M.J., Edwards D.P., et al. The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors. J Biol Chem 273 (1998) 12101-12108
28. Nolte R.T., Wisely G.B., Westin S., Cobb J.E., Lambert M.H., Kurokawa R., et al. Ligand binding and coactivator assembly of the peroxisome proliferator-activated receptor gamma. Nature 395 (1998) 137-143
29. Darimont B.D., Wagner R.L., Apriletti J.W., Stallcup M.R., Kushner P.J., Baxter J.D., et al. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev 12 (1998) 3343-3356
30. Heery D.M., Kalkhoven E., Hoare S., and Parker M.G. A signature motif in transcriptional coactivators mediates binding to nuclear receptors. Nature 387 (1997) 733-736
31. Germain P., Iyer J., Zechel C., and Gronemeyer H. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature 415 (2002) 187-192
32. Bannister A.J., and Kouzarides T. The CBP-coactivator is a histone acetyltransferase. Nature 384 (1996) 641-643
33. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., and Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87 (1996) 953-959
34. Voegel J.J., Heine M.J., Tini M., Vivat V., Chambon P., and Gronemeyer H. The coactivator TIF2 contains three nuclear receptor binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J 17 (1998) 507-519
35. McInerney E.M., Rose D.W., Flynn S.E., Westin S., Mullen T.M., Krones A., et al. Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev 12 (1998) 3357-3368
36. Janknecht R., and Hunter T. A growing coactivator network. Nature 383 (1996) 22-23
37. Chen J.D. Steroid/nuclear receptor coactivators. Vitam Horm 58 (2000) 391-448
38. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85 (1996) 403-414
39. Malik S., and Roeder R.G. Transcriptional regulation through mediator-like coactivators in yeast and metazoan cells. Trends Biochem Sci 25 (2000) 277-283
40. Cosma M.P. Ordered recruitment: gene-specific mechanism of transcription activation. Mol Cell 10 (2002) 227-236
41. Cheung P., Allis C.D., and Sassone-Corsi P. Signaling to chromatin through histone modifications. Cell 103 (2000) 263-271
42. Orphanides G., and Reinberg D. RNA polymerase II elongation through chromatin. Nature 407 (2000) 471-475
43. Dilworth F.J., and Chambon P. Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription. Oncogene 20 (2001) 3047-3054
44. Adelman K., and Lis J.T. How does Pol II overcome the nucleosome barrier?. Mol Cell 9 (2002) 451-452
45. Fry C.J., and Peterson C.L. Chromatin remodeling enzymes: who's on first?. Curr Biol 11 (2001) R185-R197
46. Aalfs J.D., and Kingston R.E. What does chromatin remodeling mean?. Trends Biochem Sci 25 (2000) 548-555
47. Chen H., and Evans R. A transcriptional corepressor that interacts with nuclear hormone receptors. Nature 377 (1995) 454-457
48. Horlein A.J., Naar A.M., Heinzel T., Torchia J., Gloss B., Kurokawa R., et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor corepressor. Nature 377 (1995) 397-404
49. Dressel U., Thormeyer D., Altincicek B., Paulutat A., Eggert M., Schneider S., et al. Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily. Mol. Cell Biol 19 (1999) 3383-3394
50. Perissi V., Staszewski L.M., McInerney E.M., Kurokawa R., Krones R., Rose D.W., et al. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev 13 (1999) 3198-3208
51. Ordentlich P., Downes M., and Evans R.M. Corepressors and nuclear hormone receptor function. Curr Top Microbiol Immunol 254 (2001) 101-116
52. Lavigne A.C., Mengus G., Gangloff Y.G., Wurtz J.M., and Davidson I. Human TAF(II)55 interacts with the vitamin D(3) and thyroid hormone receptors and with derivatives of the retinoid X receptor that have altered transactivation properties. Mol Cell Biol 19 (1999) 5486-5494
53. Horwitz K.B., Jackson T.A., Bainm D.L., Richer J.K., Takimoto G.S., and Tung L. Nuclear receptor coactivators and corepressors. Mol Endocrinol 10 (1996) 1167-1177
54. Nagy L., Kao H.Y., Love J.D., Li C., Banayo E., Gooch J.T., et al. Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev 13 (1999) 3209-3216
55. Heinzel T., Tavinsky R.M., Mullen T.M., Soderstrom M., Laherty C.D., Torchia J., et al. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387 (1997) 43-48
56. Alland L., Muhle R., Hou H., Potes J., Chin L., Schreiber-Agus N., et al. Role for NCoR and histone deacetylase in Sin3-mediatedd transcriptional repression. Nature 387 (1997) 49-55
57. Jones P.L., Sachs L.M., Rouse N., Wade P.A., and Shi Y.-B. Multiple NCoR complexes contain distinct histone deacetylases. J Biol Chem 276 (2001) 8807-8811
58. Kouzarides T. Histone methylation in transcriptional control. Curr Opin Genet Dev 12 (2002) 198-209
59. Jenuwin T., and Allis C.D. Translating the histone code. Science 293 (2001) 1074-1080
60. Delva L., Bastie J.N., Rochette-Egly C., Kraiba R., Balitrand N., Despouy G., et al. Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex. Mol Cell Biol 19 (1999) 7158-7167
61. Dong D., and Noy N. Heterodimer formation by retinoid X receptor: regulation by ligands and by the receptor's self-association properties. Biochemistry 37 (1998) 10691-10700
62. Budhu A.S., and Noy N. Direct channeling of retinoic acid between cellular retinoic acid-binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid-induced growth arrest. Mol Cell Biol 22 (2002) 2632-2641
63. Wang J.C. The path of DNA in the nucleosome. Cell 29 (1982) 724-726
64. Richmond T.J., Finch J.T., Rushton B., Rhodes D., and Klug A. Structure of the nucleosome core particle at 7 A resolution. Nature 311 (1984) 532-537
65. Felsenfeld G., and McGhee J.D. Structure of the 30 nm chromatin fiber. Cell 44 (1986) 375-377
66. Chen H., Lin R.J., Xie W., Wilpitz D., and Evans R.M. Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell 98 (1999) 675-686
67. Strahl B.D., and Allis C.D. The language of covalent histone modifications. Nature 403 (2000) 41-45
68. Roth S.Y., Denu J.M., and Allis C.D. Histone acetyltransferases. Ann Rev Biochem 70 (2001) 81-120
69. Narlikar G.J., Fan H.Y., and Kingston R.E. Cooperation between complexes that regulate chromatin structure and transcription. Cell 108 (2002) 475-487
70. Ito M., Yuabn C.X., Mallik S., Gu W., Fondell J.D., Yamamura S., et al. Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol Cell 3 (1999) 361-370
71. Woychik N.A., and Hampsey M. The RNA polymerase II machinery: structure illuminates function. Cell 108 (2002) 453-463
72. Kingston R.E., and Narlikar G.J. ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. Genes Dev 13 (1999) 2339-2352
73. Delmotte M.H., Tahayato A., Formstecher P., and Lefebvre P. Serine 157, A retinoic acid receptor alpha residue phosphorylated by protein kinase C in vitro, is involved in RXR.RARalpha heterodimerization and transcriptional activity. J Biol Chem 274 (1999) 38225-38231
74. Rochette-Egly C. Nuclear receptors: integration of multiple signalling pathways through phosphorylation. Cell Signal 15 (2003) 355-366
75. Bastien J., and Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328 (2004) 1-16
76. Rochette-Egly C., Oulad-Abdelghani M., Staub A., Pfister V., Scheuer I., Chambon P., et al. Phosphorylation of the retinoic acid receptor-alpha by protein kinase A. Mol Endocrinol 9 (1995) 860-871
77. Lee H.Y., Suh Y.A., Robinson M.J., Clifford J.L., Hong W.K., Woodgett J.R., et al. Stress pathway activation induces phosphorylation of retinoid X receptor. J Biol Chem 275 (2000) 32193-32199
78. Matsushima-Nishiwaki R., Okuno M., Adachi S., Sano T., Akita K., Moriwaki H., et al. Phosphorylation of retinoid X receptor alpha at serine 260 impairs its metabolism and function in human hepatocellular carcinoma. Cancer Res 61 (2001) 7675-7682
79. Hong S.H., and Privalsky M.L. The SMRT corepressor is regulated by a MEK-1 kinase pathway: inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export. Mol Cell Biol 20 (2000) 6612-6625
80. Keriel A., Stary A., Sarasin A., Rochette-Egly C., and Egly J.M. XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARalpha. Cell 109 (2002) 125-135
81. Zhu J., Gianni M., Kopf E., Honore N., Chelbi-Alix M., Koken M., et al. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor a (RARa) and oncogenic RARa fusion proteins. Proc Natl Acad Sci U S A 96 (1999) 14807-14812
82. Kopf E., Plassat J.L., Vivat V., de The H., Chambon P., and Rochette-Egly C. Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors alpha and gamma through the ubiquitin-proteasome pathway. J Biol Chem 275 (2000) 33280-33288
83. Tanaka T., Rodriguez de la Concepcion M.L., and De Luca L.M. Involvement of all-trans-retinoic acid in the breakdown of retinoic acid receptors alpha and gamma through proteasomes in MCF-7 human breast cancer cells. Biochem Pharmacol 61 (2001) 1347-1355
84. Conaway R.C., Brower C.S., and Conaway J.W. Emerging roles of ubiquitin in transcription regulation. Science 296 (2002) 1254-1258
85. Gianni M., Kopf E., Bastien J., Oulad-Abdelghani M., Garattini E., Chambon P., et al. Down-regulation of the phosphatidylinositol 3-kinase/Akt pathway is involved in retinoic acid-induced phosphorylation, degradation, and transcriptional activity of retinoic acid receptor gamma 2. J Biol Chem 277 (2002) 24859-24862
86. DeMartino G.N., and Slaughter C.A. The proteasome, a novel protease regulated by multiple mechanisms. J Biol Chem 274 (1999) 22123-22126
87. Gianni M., Bauer A., Garattini E., Chambon P., and Rochette-Egly C. Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-induced RARg degradation and transactivation. EMBO J 21 (2002) 3760-3769
88. Gonzalez F., Delahodde A., Kodadek T., and Johnston S.A. Recruitment of a 19S proteasome subcomplex to an activated promoter. Science 296 (2002) 548-550
89. Muratani M., and Tansey W.P. How the ubiquitin-proteasome system controls transcription. Nat Rev Mol Cell Biol 4 (2003) 192-201
90. Zimmerman T.L., Thevananther S., Ghose R., Burns A.R., and Karpen S.J. Nuclear export of retinoid X receptor alpha in response to interleukin-1beta-mediated cell signaling: roles for JNK and SER260. J Biol Chem 281 (2006) 15434-15440
91. Osburn D.L., Shao G., Seidel H.M., and Schulman I.G. Ligand-dependent degradation of retinoid X receptors does not require transcriptional activity or coactivator interactions. Mol Cell Biol 21 (2001) 4909-4918
92. Isseman I., and Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347 (1990) 645-650
93. Dreyer C., Keller H., Mahfoudi A., Loudet V., Krey G., and Wahli W. Positive regulation of peroxisomal β-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors. Biol Cell 77 (1993) 67-77
94. Tonotoz P., Hu E., and Speigelman B.M. Stimulation of adipogenesis in fibroblasts by PPAR gamma2, a lipid activated transcription factor. Cell 79L (1994) 1147-1156
95. Osumi T., Wen J.K., and Hashimoto T. Two cis-acting elements in the peroxisome proliferators-responsive element enhancer region of rat acyl-CoA oxidase gene. Biochem Biophys Res Commun 175 (1991) 866-871
96. Tugwood J.D., Isseman I., Anderson R.G., Bundell K.R., McPheat W.L., and Green S. The mouse peroxisome proliferators activated receptor recognizes a response element in the 5′-flanking sequence of rat acyl coA oxidase. Embo J 11 (1992) 433-439
97. Zhang X.-K., Lehmann J., Hoffman B., Dawson M., Camerson J., Graupner G., et al. Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature 358 (1992) 587-591
98. Desvergne B., and Wahli W. Peroxisome proliferators-activated receptors: nuclear control of metabolism. Endocr Rev 20 (1999) 649-688
99. Reddy J.K. Peroxisome proliferators and peroxisome proliferator-activated receptor alpha. Am J Pathol 164 (2004) 2305-2321
100. Bourguet W., Ruff M., Chambon P., Gronemeyer H., and Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature 375 (1995) 377-382
101. Egea P.F., Rochel N., Birck C., Vachette P., Timmins P.A., and Moras D. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR. J Mol Biol 307 (2001) 557-576
102. Jump D.B., Botolin D., Wang Y., Xu J., Christian B., and Demeure O. Fatty acid regulation of hepatic gene transcription. J Nutr 135 (2005) 2503-2506
103. Yang W., Rachez C., and Freedman L.P. Discrete roles for peroxisome proliferators-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators. Mol Cell Biol 20 (2000) 8008-8017
104. Ijpenberg A., Tan N.S., Gelman L., Kersten S., Seydoux J., Xu J., et al. Polarity and specific sequence requirements of peroxisome proliferators-activated receptor/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element. Embo J 23 (2004) 2083-2091
105. Balmer J.E., and Blomhoff R. Gene expression regulation by retinoic acid. J Lipid Res 43 (2002) 1773-1808
106. Granner D.K., Andreone T., Sasaki K., and Beale E. Inhibition of transcription of the phosphoenolpyruvate carboxykinase gene by insulin. Nature 305 (1983) 549-551
107. Imai E., Stromstedt P.E., Quinn P.D., Carlstedt-Duke J., Gustafsson J., and Granner D.K. Characterization of a complex glucocorticoid response unit in the phosphoneolpyruvate carboxyukinase gene. Mol Cell Biol 10 (1990) 4712-4719
108. Lamers W.H., Hanson R.W., and Meisner H.M. cAMP stimulates transcription of the gene for cytosolic phosphoenolpuriuvate carboxykinase in rat liver nuclei. Proc Natl Acad Sci U S A 79 (1982) 5137-5141
109. McGrane M.M., Yun J.S., Moorman A.F., Lamers W.H., Hendrick G.K., Arafah B.M., et al. Metabolic effects of developmental, tissue- and cell-specific expression of a chimeric phosphoenolpyruvate carboxykinase (GTP)/bovine growth hormone gene in transgenic mice. J Biol Chem 265 (1990) 22371-22379
110. McGrane M.M., and Hanson R.W. From diet to DNA: dietary patterning of gene expression. Nutr Clin Pract 7 (1992) 16-21
111. O'Brien R.M., Lucas P.C., Forest C.D., Magnuson M.A., and Granner D.K. Identification of a sequence in the PEPCK gene that mediates a negative effect of insulin on transcription. Science 249 (1990) 533-537
112. Sasaki K., Cripe T.P., Kocks S.R., Adreone T.L., Petersen D.D., Bealse E.G., et al. Multihormonal regulation of phosphoenolpyruvate carboxykinasse gene transcription. J Biol Chem 259 (1984) 8288-8292
113. Short J.M., Wynshaw-Boris A., Short H.P., and Hanson R.W. Characterization of phosphoenolpyruvate carboxykinase (GTP) promoter-regulatory region. J Biol Chem 261 (1986) 9721-9726
114. Hall R.K., Scott D.K., Noisin E.L., Lucas P.C., and Granner D.K. Activation of the phosphoenolpyruvate carboxykinase gene retinoic acid response element is dependent on a retinoic acid receptor/coregulator complex. Mol Cell Biol 12 (1992) 5527-5535
115. Lucas P.C., O'Brien R.M., Mitchell J.A., Davis C.M., Imai E., Forman B.M., Samuels H.H., and Granner D.K. A retinoic acid response element is part of a pleiotropic domain in the phosphoenolpyruvate carboxykinase gene. Proc Natl Acad Sci U S A 88 (1991) 2184
116. Lucas P.C., Forman B.M., Samuels H.H., and Granner D.K. Specificity of a retinoic acid response element in the phosphoenolpyruvate carboxykinase gene promoter: consequences of both retinoic acid and thyroid hormone receptor binding. Mol Cell Biol 11 (1991) 5164-5170
117. Scott D.K., Mitchell J.A., and Granner K.D. Identification and characterization of a second retinoic acid response element in the phosphoenolpyruvate carboxykinase gene promoter. J Biol Chem 271 (1996) 6260-6264
118. Devine J.H., Eubank D.W., Clouthier D.E., Tontonoz P., Spiegelman B.M., Hammer R.E., et al. Adipose expression of the phosphoenolpyruvate carboxykinase promoter requires peroxisome proliferators-activated receptor gamma and 9-cis retinoic acid receptor binding to an adipocyte-specific enhancer in vivo. J Biol Chem 274 (1999) 13604-13612
119. Shin D.-J., and McGrane M.M. Vitamin A regulates genes involved in hepatic gluconeogenesis in mice: phosphoenolpyruvate carboxykinase, fructose-1,6-bisphosphatase and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. J Nutr 127 (1997) 1274-1278
120. Shin D.-J., Odom D.P., Scribner K.B., Ghoshal S., and McGrane M.M. Retinoid regulation of the phosphoenolpyruvate carboxykinase gene in liver. Mol Cell Endocrinol 195 (2002) 39-54
121. Scribner K.B., Odom D.P., and McGrane M.M. Nuclear receptor binding to the retinoic acid response elements of the phosphoenolpyruvate carboxykinase gene in vivo: effects of vitamin A deficiency. J Nutr Biochem (2006)
122. Eubank D.W., Duplus E., Williams S.C., Forest C., and Beale E.G. Peroxisome proliferator-activated receptor gamma and chicken ovalbumin upstream promoter transcription factor II negatively regulate the phosphoenolpyruvate carboxykinase promoter via a common element. J Biol Chem 276 (2001) 30561-30569
123. Leone T.C., Weinheimer C.J., and Kelly D.P. A critical role for PPAR in the cellular fasting response: the PPAR alpha null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci U S A 96 (1999) 7473-7477
124. Xu J., Xiao G., Trujillo C., Chang V., Blanco L., Joseph S.B., et al. PPARalppha influences substrate utilization for hepatic glucose production. J Biol Chem 277 (2002) 50237-50244
125. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., and Wahli W. Roles of PPARs in health and disease. J Clin Invest 103 (1999) 1489-1498
126. Scribner K.B., Odom D.P., and McGrane M.M. Vitamin A status in mice affects the histone code of the phosphoenolpyruvate carboxykinase gene in liver. J Nutr 135 (2005) 2774-2779
127. Puigserver P., Adelmant G., Wu Z., Fan M., Xu J., O'Malley B., et al. Activation of PPARgamma coactivator 1 through transcription factor socking. Science 286 (1999) 1368-1371
128. Monsalve M., Wu Z., Adelmant G., Puigserver P., Fan M., and Spiegelman B.M. Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-1. Mol Cell 6 2 (2002) 307-316
129. Rhee J., Inoue Y., Yoon J.C., Puigserver P., Fan M., Gonzales F.J., et al. Regulation of hepatic fasting response by PPARgamma coactivator 1 alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc Natl Acad Sci U S A 100 (2003) 4012-4017
130. Hebbes T.R., Thorne A.W., and Crane-Robinson C. A direct link between core histone acetylation and transcriptionally active chromatin. Embo J 7 (1988) 1395-1402
131. Edmondson D.G., Davie J.K., Zhou J., Mirnikjoo B., Tatchell K., and Dent S.Y.R. Site specific loss of acetylation upon phosphorylation of histone H3. J Biol Chem 277 (2002) 29496-29502
132. Kuo M.-H., Brownell J.E., Sobel R.E., Ranalli T.A., Cook R.G., Edmondson D.G., et al. Transcription-linked acetylation by Gcn5p of histones H3 and H4 at specific lysines. Nature 383 (1996) 269-272
133. Chen H., Lin R.J., Schiltz R.L., Chakravarti D., Nash A., Nagy L., et al. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90 (1997) 569-580
134. Zhang W., and Bieker J.J. Acetylation and modulation of erythroid druppel-like factor activity by interaction with histone acetyltransferases. Proc Natl Acad Sci U S A 95 (1998) 9855-9860
135. Grant P.A., Eberharter A., John S., Cook R.G., Turner B.M., and Workman J.L. Expanded lysine acetylation specificity of Gcn5 in native complexes. J Biol Chem 274 (1999) 5895-5900
136. Spencer T.E., Jenster G., Burcin M.M., Allis C.D., Zhou J., Mizzen C., et al. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389 (1997) 9498
137. Schiltz R.L., Mizzen C.A., Vassilev A., Cook R.G., Allis C.D., and Nakatani Y. Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. J Biol Chem 274 (1999) 1189-1192
138. Ito K., Barnes P.J., and Adcock I.M. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 20 (2000) 6891-6903
139. Xu J., and Li Q. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol Endocrinol 17 (2003) 1681-1692
140. Soutoglou E., Katrakili N., and Talianidis I. Acetylation regulates transcription factor activity at multiple levels. Mol Cell 5 (2000) 745-751
141. Scribner K.B., and McGrane M.M. RNA polymerase II association with the phosphoenolpyruvate carboxykinase (PEPCK) promoter is reduced in vitamin A deficient liver. J Nutr 133 (2003) 4112-4117
142. Duong D.T., Waltner-Law M.E., Sears R., Sealy L., and Granner D.K. Insulin inhibits hepatocellular glucose production by utilizing liver-enriched transcriptional inhibitory protein to disrupt the association of CREB-binding protein and RNA polymerase II with the phosphoenolpyruvate carboxykinase gene promoter. J Biol Chem 277 (2002) 32234-32242